Difference between revisions of "LncRNAWiki:G"
| (One intermediate revision by the same user not shown) | |||
| Line 129: | Line 129: | ||
|N/A | |N/A | ||
|"Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)" | |"Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)" | ||
| + | |_ | ||
| + | |- | ||
| + | |''G2E3-AS1'' | ||
| + | |[[G2E3-AS1]] | ||
| + | |CAT1647 | ||
| + | |G2E3 antisense RNA 1 | ||
| + | |Bladder cancer | ||
| + | |- | ||
| + | |''GCASPC'' | ||
| + | |[[GCASPC]] | ||
| + | |TCONS_00011605, RP1-56L9.7-001, lnc-SOD2-1 | ||
| + | |gall bladder cancer associated suppressor of pyruvate carboxylase lncRNA | ||
| + | |gallbladder cancer | ||
| + | |- | ||
| + | |''GPRC5D-AS1'' | ||
| + | |[[GPRC5D-AS1]] | ||
| + | |RP11-392P7.6 | ||
| + | |GPRC5D and HEBP1 antisense RNA 1 | ||
| + | |Colorectal cancer | ||
| + | |- | ||
| + | |''GSEC'' | ||
| + | |[[GSEC]] | ||
| + | |ST3GAL4-AS1, DCPS-AS1, FLJ39051 | ||
| + | |G-quadruplex forming sequence containing lncRNA | ||
| + | |colon cancer | ||
| + | - | ||
| + | |''GABPB1-IT1'' | ||
| + | |[[GABPB1-IT1]] | ||
| + | |FLJ10038 | ||
| + | |GABPB1 intronic transcript | ||
|_ | |_ | ||
|} | |} | ||
Latest revision as of 12:36, 29 June 2017
| Name | Transcript ID | Alias | Description | Disease | |||||
|---|---|---|---|---|---|---|---|---|---|
| GABPB1-AS1 | GABPB1-AS1 | N/A | GABPB1 antisense RNA 1 | _ | |||||
| GACAT1 | ENST00000441383.1 | "LINC00876, AC096655.1-002" | gastric cancer associated transcript 1 (non-protein coding) | gastric cancer | |||||
| GACAT2 | ENST00000579368.1 | HMlincRNA717 | gastric cancer associated transcript 2 (non-protein coding) | gastric cancer | |||||
| GACAT3 | ENST00000426539.1 | lncRNA-AC130710 | gastric cancer associated transcript 3 (non-protein coding) | gastric cancer | |||||
| GAPLINC | GAPLINC | TCONSN/A00026238 | "gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA" | gastric cancer | |||||
| GAS1RR | GAS1RR | LncRNA-Hh | GAS1 adjacent regulatory RNA | _ | |||||
| GAS5 | NONHSAT007663 | "SNHG2, ENSG00000234741" | _ | autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus | |||||
| GAS6-AS1 | GAS6-AS1 | N/A | GAS6 antisense RNA 1 | _ | |||||
| GAS8-AS1 | GAS8-AS1 | N/A | GAS8 antisense RNA 1 | _ | |||||
| GATA3-AS1 | GATA3-AS1 | N/A | GATA3 antisense RNA 1 | _ | |||||
| GATA6-AS1 | GATA6-AS1 | locus5689 | GATA6 antisense RNA 1 (head to head) | _ | |||||
| GDNF-AS1 | GDNF-AS1 | GDNFOS | GDNF antisense RNA 1 (head to head) | _ | |||||
| GHET1 | GHET1 | lncRNA-GHET1 | gastric carcinoma proliferation enhancing transcript 1 | gastric cancer | |||||
| GHRLOS | NONHSAT087920 | "NCRNA00068,GHRL-AS1" | ghrelin opposite strand/antisense RNA | obesity, diabetes and cancer | |||||
| GLIDR | GLIDR | "MGC21881, TCONSN/A00015562" | glioblastoma down-regulated RNA | glioblastoma | |||||
| GLIS3-AS1 | GLIS3-AS1 | MGC16153 | GLIS3 antisense RNA 1 | _ | |||||
| GNAS-AS1 | lnc-CTSZ-5:1 | "GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590" | neuroendocrine secretory protein (Nesp) antisense. | pseudohypoparathyroidism type Ib | |||||
| GNG12-AS1 | GNG12-AS1 | N/A | GNG12 antisense RNA 1 | _ | |||||
| GPR1-AS | NONHSAT076558 | GPR1AS | GPR1 antisense RNA | _ | |||||
| GTSCR1 | GTSCR1 | N/A | "Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)" | _ | |||||
| G2E3-AS1 | G2E3-AS1 | CAT1647 | G2E3 antisense RNA 1 | Bladder cancer | |||||
| GCASPC | GCASPC | TCONS_00011605, RP1-56L9.7-001, lnc-SOD2-1 | gall bladder cancer associated suppressor of pyruvate carboxylase lncRNA | gallbladder cancer | |||||
| GPRC5D-AS1 | GPRC5D-AS1 | RP11-392P7.6 | GPRC5D and HEBP1 antisense RNA 1 | Colorectal cancer | |||||
| GSEC | GSEC | ST3GAL4-AS1, DCPS-AS1, FLJ39051 | G-quadruplex forming sequence containing lncRNA | colon cancer
- |
GABPB1-IT1 | GABPB1-IT1 | FLJ10038 | GABPB1 intronic transcript | _ |
